Sanofi Consumer Healthcare India Limited (SANOFICONR) — Board Meeting
Sanofi Consumer Healthcare India held its 3rd Annual General Meeting on 26 June 2026 via video conference, approving the 2025 audited standalone financial statements, declaring a final dividend of Rs 75 per equity share, reappointing Director Stanislas Camart, appointing Price Waterhouse & Co as statutory auditors, and ratifying cost auditor remuneration. Chairman Amit Jain chaired the session, with 12 shareholder queries addressed during a Q&A. The meeting concluded at 5:10 p.m. IST after enabling final e-voting.
About Sanofi Consumer Healthcare India Limited (SANOFICONR)
Healthcare · Pharmaceuticals & Biotechnology · Listed on NSE
📡 Get AI alerts when SANOFICONR files next
Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions
Track SANOFICONR — Free💡 Ask AI about this filing
📊 More SANOFICONR filings
- share transfer — 9 July 2026 Sanofi Consumer Healthcare India Limited disclosed a SEBI-mandated certificate from its share transf...
- 🟡 Board Meeting — 29 June 2026 The 3rd Annual General Meeting of Sanofi Consumer Healthcare India Limited was held on 26 June 2026,...
- 🟡 Board Meeting — 29 June 2026 Sanofi Consumer Healthcare India announced that shareholders approved Price Waterhouse & Co Chartere...
- 🔴 Financial Results — 4 June 2026 Sanofi Consumer Healthcare India Limited announced its 3rd Annual General Meeting on 26 June 2026 at...
- Announcement — 30 April 2026 Sanofi Consumer Healthcare India announced the resignation of statutory auditor Kalyaniwalla & Mistr...
🔥 Also filed on 26 June 2026
Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.
📡 Get AI alerts when SANOFICONR files new disclosures
Track SANOFICONR filings, board meetings, and corporate actions. Free email alerts at 5 PM.
Track SANOFICONR — FreeFree account · 2 AI queries/day
© 2026 StockFin.ai — AI-powered Indian stock research